Annual report
6942.TEDINET S100P8PJ
Period2021-04-01 → 2022-03-31
Filed2022-09-28
StandardJapan GAAP
ConsolidatedYes
Data checks23 of 24 passed
Amends S100P15Z. Amended by S100P91P (2022-09-28).
Key figures · 144
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥11.8bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥11.4bn | 2020-04-01 → 2021-03-31 | Cons. | Net sales |
| Revenue | ¥9.8bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥4.5bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥3.8bn | 2017-04-01 → 2018-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥883m | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Operating income | ¥731m | 2020-04-01 → 2021-03-31 | Cons. | Operating income |
| Ordinary income | ¥889m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥749m | 2020-04-01 → 2021-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥156m | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥343m | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥221m | 2017-04-01 → 2018-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥875m | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥610m | 2020-04-01 → 2021-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥613m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥502m | 2020-04-01 → 2021-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥160m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥391m | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥571m | 2017-04-01 → 2018-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥613m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Net income | ¥502m | 2020-04-01 → 2021-03-31 | Cons. | Profit loss |
| Total assets | ¥8.6bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥8.6bn | at 2021-03-31 | Cons. | Assets |
| Total assets | ¥8.9bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥6.8bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥2.7bn | at 2018-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥6.6bn | at 2022-03-31 | Cons. | Liabilities |
| Total liabilities | ¥7.2bn | at 2021-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥2.0bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.4bn | at 2021-03-31 | Cons. | Net assets |
| Net assets / equity | ¥884m | at 2020-03-31d | Cons. | Net assets |
| Net assets / equity | ¥724m | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥616m | at 2018-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.3bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.1bn | at 2021-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.3bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.1bn | at 2021-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2020-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.7bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.8bn | at 2018-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥1.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.2bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥83m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥534m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥278m | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥151m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥86m | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥328m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.6bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥601m | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥696m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥793m | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥717m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥3.1bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥256m | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥228.11 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥186.65 | 2020-04-01 → 2021-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥59.34 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-161.78 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥261.07 | 2017-04-01 → 2018-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥745.63 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥515.39 | at 2021-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥328.63 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥269.25 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥281.22 | at 2018-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 23.3% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 16.1% | at 2021-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 9.9% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 10.6% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 23.2% | at 2018-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 36.2% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 44.2% | 2020-04-01 → 2021-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 19.8% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | -58.3% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 173.5% | 2017-04-01 → 2018-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 209 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 228 | at 2021-03-31 | Cons. | Number of employees |
| Employees | 230 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 122 | at 2019-03-31d | Cons. | Number of employees |
| Employees | 66 | at 2018-03-31d | Cons. | Number of employees |
| Revenue | ¥395m | 2021-04-01 → 2022-03-31 | Standalone | Operating revenue1 |
| Revenue | ¥39,000 | 2020-04-01 → 2021-03-31 | Standalone | Net sales |
| Revenue | ¥310m | 2020-04-01 → 2021-03-31 | Standalone | Operating revenue1 |
| Revenue | ¥213m | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥398m | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥104m | 2017-04-01 → 2018-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥45m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Operating income | −¥49m | 2020-04-01 → 2021-03-31 | Standalone | Operating income |
| Ordinary income | ¥115m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥76m | 2020-04-01 → 2021-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥410m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥160m | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥229m | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥93m | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥76m | 2020-04-01 → 2021-03-31 | Standalone | Income before income taxes |
| Net income | ¥149m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥216m | 2020-04-01 → 2021-03-31 | Standalone | Profit loss |
| Net income | −¥262m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥161m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥306m | 2017-04-01 → 2018-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥3.0bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥3.6bn | at 2021-03-31 | Standalone | Assets |
| Total assets | ¥3.4bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥4.2bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.1bn | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥2.2bn | at 2022-03-31 | Standalone | Liabilities |
| Total liabilities | ¥2.9bn | at 2021-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥772m | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥623m | at 2021-03-31 | Standalone | Net assets |
| Net assets / equity | ¥408m | at 2020-03-31d | Standalone | Net assets |
| Net assets / equity | ¥670m | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥330m | at 2018-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥155m | at 2022-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥433m | at 2021-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥55.25 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥80.15 | 2020-04-01 → 2021-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-97.26 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-66.58 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥139.78 | 2017-04-01 → 2018-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥287.1 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥231.85 | at 2021-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥151.74 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥249.02 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥150.95 | at 2018-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 26.1% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 17.5% | at 2021-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 12.1% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 15.9% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 29.7% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 21.3% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 41.8% | 2020-04-01 → 2021-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | -48.5% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | -32.2% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 172.4% | 2017-04-01 → 2018-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 2,737,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,737,000 | at 2021-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,737,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,737,000 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,237,000 | at 2018-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 9 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 10 | at 2021-03-31 | Standalone | Number of employees |
| Employees | 11 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 9 | at 2019-03-31d | Standalone | Number of employees |
| Employees | 11 | at 2018-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 76
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2022-03-31 | −¥203,000 |
| Dispensing Pharmacy And Related Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥145m |
| Dispensing Pharmacy And Related Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥53m |
| Dispensing Pharmacy And Related Businessreportable segment | employees | at 2022-03-31 | 143 pure |
| Dispensing Pharmacy And Related Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥7.0bn |
| Dispensing Pharmacy And Related Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥7.0bn |
| Dispensing Pharmacy And Related Businessreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥9m |
| Dispensing Pharmacy And Related Businessreportable segment | segment assets | at 2022-03-31 | ¥6.0bn |
| Dispensing Pharmacy And Related Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥390m |
| Internet Related Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥6m |
| Internet Related Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥2m |
| Internet Related Businessreportable segment | employees | at 2022-03-31 | 44 pure |
| Internet Related Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥1.2bn |
| Internet Related Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥1.2bn |
| Internet Related Businessreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥17m |
| Internet Related Businessreportable segment | segment assets | at 2022-03-31 | ¥1.2bn |
| Internet Related Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥121m |
| Telecommunications Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥4m |
| Telecommunications Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥2m |
| Telecommunications Businessreportable segment | employees | at 2022-03-31 | 13 pure |
| Telecommunications Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥3.6bn |
| Telecommunications Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥3.6bn |
| Telecommunications Businessreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥30m |
| Telecommunications Businessreportable segment | segment assets | at 2022-03-31 | ¥1.6bn |
| Telecommunications Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥484m |
| —segment total | capex | 2021-04-01 → 2022-03-31 | ¥156m |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥58m |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥11.8bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥11.8bn |
| —segment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥56m |
| —segment total | segment assets | at 2022-03-31 | ¥8.8bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥995m |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥156m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-04-01 → 2022-03-31 | ¥58m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥11.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥11.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥56m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥8.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥995m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2021-03-31 | ¥3m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2020-04-01 → 2021-03-31 | −¥8m |
| Dispensing Pharmacy And Related Businessreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥10m |
| Dispensing Pharmacy And Related Businessreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥59m |
| Dispensing Pharmacy And Related Businessreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥7.1bn |
| Dispensing Pharmacy And Related Businessreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥7.1bn |
| Dispensing Pharmacy And Related Businessreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥9m |
| Dispensing Pharmacy And Related Businessreportable segment | segment assets | at 2021-03-31 | ¥6.4bn |
| Dispensing Pharmacy And Related Businessreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥362m |
| Internet Related Businessreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥36m |
| Internet Related Businessreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥1m |
| Internet Related Businessreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥983m |
| Internet Related Businessreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥969m |
| Internet Related Businessreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥14m |
| Internet Related Businessreportable segment | segment assets | at 2021-03-31 | ¥923m |
| Internet Related Businessreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥87m |
| Telecommunications Businessreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥3m |
| Telecommunications Businessreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥2m |
| Telecommunications Businessreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥3.3bn |
| Telecommunications Businessreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥3.3bn |
| Telecommunications Businessreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥2m |
| Telecommunications Businessreportable segment | segment assets | at 2021-03-31 | ¥1.2bn |
| Telecommunications Businessreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥434m |
| —segment total | capex | 2020-04-01 → 2021-03-31 | ¥49m |
| —segment total | depreciation | 2020-04-01 → 2021-03-31 | ¥63m |
| —segment total | revenue | 2020-04-01 → 2021-03-31 | ¥11.4bn |
| —segment total | revenue external | 2020-04-01 → 2021-03-31 | ¥11.4bn |
| —segment total | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥25m |
| —segment total | segment assets | at 2021-03-31 | ¥8.5bn |
| —segment total | segment profit | 2020-04-01 → 2021-03-31 | ¥883m |
| Total Of Reportable Segments And Otherssegment total | capex | 2020-04-01 → 2021-03-31 | ¥49m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2020-04-01 → 2021-03-31 | ¥63m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-04-01 → 2021-03-31 | ¥11.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-04-01 → 2021-03-31 | ¥11.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥25m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2021-03-31 | ¥8.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-04-01 → 2021-03-31 | ¥875m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,330
| Item | Context | Value | Unit |
|---|---|---|---|
| Net assets per share (5-year summary) | Prior2YearInstant | 328.63 | |
| Net assets per share (5-year summary) | Prior1YearInstant | 515.39 | |
| Net assets per share (5-year summary) | CurrentYearInstant | 745.63 | |
| Basic earnings loss per share (5-year summary) | Prior4YearDuration | 261.07 | |
| Basic earnings loss per share (5-year summary) | Prior3YearDuration | -161.78 | |
| Basic earnings loss per share (5-year summary) | Prior2YearDuration | 59.34 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 186.65 | |
| Basic earnings loss per share (5-year summary) | CurrentYearDuration | 228.11 | |
| Diluted earnings per share (5-year summary) | Prior4YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior3YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior2YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior4YearInstant | 0.232 | |
| Equity to asset ratio (5-year summary) | Prior3YearInstant | 0.106 | |
| Equity to asset ratio (5-year summary) | Prior2YearInstant | 0.099 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.161 | |
| Equity to asset ratio (5-year summary) | CurrentYearInstant | 0.233 | |
| Rate of return on equity (5-year summary) | Prior4YearDuration | 1.735 | |
| Rate of return on equity (5-year summary) | Prior3YearDuration | -0.583 | |
| Rate of return on equity (5-year summary) | Prior2YearDuration | 0.198 | |
| Rate of return on equity (5-year summary) | Prior1YearDuration | 0.442 | |
| Rate of return on equity (5-year summary) | CurrentYearDuration | 0.362 | |
| Price earnings ratio (5-year summary) | Prior4YearDuration | 5.52 | |
| Price earnings ratio (5-year summary) | Prior3YearDuration | － | |
| Price earnings ratio (5-year summary) | Prior2YearDuration | 8.43 | |
| Price earnings ratio (5-year summary) | Prior1YearDuration | 7.69 | |
| Price earnings ratio (5-year summary) | CurrentYearDuration | 4.32 | |
| Net cash provided by used in operating activities (5-year summary) | Prior4YearDuration | 278490000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior3YearDuration | -533643000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior2YearDuration | -82964000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 1230795000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYearDuration | 1068463000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior4YearDuration | 600621000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior3YearDuration | -1635797000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior2YearDuration | -328477000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | 86121000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYearDuration | -150907000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior4YearDuration | -256140000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior3YearDuration | 3087970000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior2YearDuration | -717190000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -793369000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYearDuration | -696114000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior4YearInstant | 1804152000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior3YearInstant | 2722739000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior2YearInstant | 1594089000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 2117609000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentYearInstant | 2339050000 | JPY |
| Number of employees | Prior4YearInstant | 66 | |
| Number of employees | Prior3YearInstant | 122 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 23 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | mismatch |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |